225 related articles for article (PubMed ID: 9065515)
1. An escalating dose "binge" model of amphetamine psychosis: behavioral and neurochemical characteristics.
Segal DS; Kuczenski R
J Neurosci; 1997 Apr; 17(7):2551-66. PubMed ID: 9065515
[TBL] [Abstract][Full Text] [Related]
2. Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical characterization.
Segal DS; Kuczenski R
J Pharmacol Exp Ther; 1997 Aug; 282(2):561-73. PubMed ID: 9262316
[TBL] [Abstract][Full Text] [Related]
3. Behavioral alterations induced by an escalating dose-binge pattern of cocaine administration.
Segal DS; Kuczenski R
Behav Brain Res; 1997 Nov; 88(2):251-60. PubMed ID: 9404634
[TBL] [Abstract][Full Text] [Related]
4. Long-lasting effects of escalating doses of d-amphetamine on brain monoamines, amphetamine-induced stereotyped behavior and spontaneous nocturnal locomotion.
Robinson TE; Camp DM
Pharmacol Biochem Behav; 1987 Apr; 26(4):821-7. PubMed ID: 2440058
[TBL] [Abstract][Full Text] [Related]
5. An escalating dose/multiple high-dose binge pattern of amphetamine administration results in differential changes in the extracellular dopamine response profiles in caudate-putamen and nucleus accumbens.
Kuczenski R; Segal DS
J Neurosci; 1997 Jun; 17(11):4441-7. PubMed ID: 9151761
[TBL] [Abstract][Full Text] [Related]
6. Multiple daily amphetamine administration: behavioral and neurochemical alterations.
Segal DS; Weinberger SB; Cahill J; McCunney SJ
Science; 1980 Feb; 207(4433):905-7. PubMed ID: 7188815
[TBL] [Abstract][Full Text] [Related]
7. Escalating dose-binge stimulant exposure: relationship between emergent behavioral profile and differential caudate-putamen and nucleus accumbens dopamine responses.
Segal DS; Kuczenski R
Psychopharmacology (Berl); 1999 Feb; 142(2):182-92. PubMed ID: 10102771
[TBL] [Abstract][Full Text] [Related]
8. Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine.
Kuczenski R; Segal DS; Cho AK; Melega W
J Neurosci; 1995 Feb; 15(2):1308-17. PubMed ID: 7869099
[TBL] [Abstract][Full Text] [Related]
9. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine.
Kuczenski R; Segal DS
J Neurochem; 1997 May; 68(5):2032-7. PubMed ID: 9109529
[TBL] [Abstract][Full Text] [Related]
10. Escalating dose-binge treatment with methylphenidate: role of serotonin in the emergent behavioral profile.
Segal DS; Kuczenski R
J Pharmacol Exp Ther; 1999 Oct; 291(1):19-30. PubMed ID: 10490882
[TBL] [Abstract][Full Text] [Related]
11. Caudate-putamen dopamine and stereotypy response profiles after intravenous and subcutaneous amphetamine.
Cho AK; Melega WP; Kuczenski R; Segal DS; Schmitz DA
Synapse; 1999 Feb; 31(2):125-33. PubMed ID: 10024009
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of l-ephedrine neurotoxicity with respect to hyperthermia and caudate/putamen microdialysate levels of ephedrine, dopamine, serotonin, and glutamate.
Bowyer JF; Newport GD; Slikker W; Gough B; Ferguson SA; Tor-Agbidye J
Toxicol Sci; 2000 May; 55(1):133-42. PubMed ID: 10788568
[TBL] [Abstract][Full Text] [Related]
13. Dynamic changes in sensitivity occur during the acute response to cocaine and methylphenidate.
Kuczenski R; Segal DS
Psychopharmacology (Berl); 1999 Nov; 147(1):96-103. PubMed ID: 10591874
[TBL] [Abstract][Full Text] [Related]
14. Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects.
Clausing P; Gough B; Holson RR; Slikker W; Bowyer JF
J Pharmacol Exp Ther; 1995 Aug; 274(2):614-21. PubMed ID: 7636721
[TBL] [Abstract][Full Text] [Related]
15. Human methamphetamine pharmacokinetics simulated in the rat: behavioral and neurochemical effects of a 72-h binge.
Kuczenski R; Segal DS; Melega WP; Lacan G; McCunney SJ
Neuropsychopharmacology; 2009 Oct; 34(11):2430-41. PubMed ID: 19571794
[TBL] [Abstract][Full Text] [Related]
16. Differential regional zif268 messenger RNA expression in an escalating dose/binge model of amphetamine-induced psychosis.
Shilling PD; Kelsoe JR; Kuczenski R; Segal DS
Neuroscience; 2000; 96(1):83-90. PubMed ID: 10683413
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of d- and l-amphetamine on the open field performance of rats.
Dandiya PC; Kulkarni SK
Psychopharmacologia; 1974; 39(1):67-70. PubMed ID: 4472934
[No Abstract] [Full Text] [Related]
18. Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine.
Cadoni C; Di Chiara G
Neuroscience; 1999 May; 90(2):447-55. PubMed ID: 10215150
[TBL] [Abstract][Full Text] [Related]
19. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
Castall B; Marsden CD; Naylor RJ; Pycock CJ
Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267
[TBL] [Abstract][Full Text] [Related]
20. Caudate-putamen and nucleus accumbens extracellular acetylcholine responses to methamphetamine binges.
Kuczenski R; Segal DS
Brain Res; 2001 Dec; 923(1-2):32-8. PubMed ID: 11743969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
